Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03838926
Title Tolerability Study of Trichostatin A In Subjects With Relapsed or Refractory Hematologic Malignancies
Recruitment Unknown status
Gender both
Phase Phase I
Variant Requirements No
Sponsors Vanda Pharmaceuticals
Indications

hematologic cancer

Therapies

Trichostatin A

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.